FDA chief defends agency openness
(Reuters)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20070323/hl_nm/fda__industry_dc"><img src="http://d.yimg.com/us.yimg.com/p/rids/20070322/i/r2918613973.jpg?x=130&y=91&sig=l2AvLc8oyodcagJp2lP.5Q--" align="left" height="91" width="130" alt="Food and Drug Administration Commissioner Andrew von Eschenbach speaks during Reuters Regulatory Summit in Washington, January 8, 2007. The head of the U.S. Food and Drug Administration on Thursday defended the agency against charges that staff scientists are pressured to withhold their concerns about possible risks of prescription drugs. REUTERS/Hyungwon Kang" border="0" /></a>Reuters - The head of the U.S. Food and Drug
Administration on Thursday defended the agency against charges
that staff scientists are pressured to withhold their concerns
about possible risks of prescription drugs.</p><br clear="all"/>

Read more...